Aortyx
About Aortyx
A medtech scaleup focused on innovative bioresorbable patches designed to treat aortic diseases with a minimally invasive approach.
Business Information
Target Customers
Industry Categories
Business Model
Funding Timeline
| Round | Date | Amount | Investors |
|---|---|---|---|
| Series A | Jun 12, 2025 | $13.8M | Ship2B Ventures, Clave Capital |
Founders
No founder information available.
Investors
Clave Capital
Investor
Ship2B Ventures
Investor
Recent Mentions
Congratulations to Aortyx, a brilliant medtech scaleup from our Cardiovascular Therapies market group, on securing a €13.8M Series A funding round! This investment, led by Ship2B Ventures and Clave Capital, is crucial, bringing their innovative bioresorbable patch – designed https://t.co/4h7yQZbC43
Congratulations to Aortyx, a brilliant medtech scaleup from our Cardiovascular Therapies market group, on securing a €13.8M Series A funding round! This investment, led by Ship2B Ventures and Clave Capital, is crucial, bringing their innovative bioresorbable patch – designed https://t.co/f8yx0G2Fpk
New Raise 🏛️ Company: Aortyx 🔗 Website: https://t.co/cZyDNNvGNs 📊 Amount: €13.8 Million 🔄 Round: Series A 🧮 Valuation: N/A ⚙️ Industry: Medical Technology
Similar Startups
MedVital
86% matcha forward-thinking MedTech startup focused on skin repair, wound healing, and aesthetic care
Allay Therapeutics
85% matchAllay Therapeutics is pioneering ultra-sustained analgesic products to transform post-surgical pain ...
AusperBio
85% matchA clinical-stage biotechnology company dedicated to advancing targeted oligonucleotide therapies.
Axle Health
84% matchAxle Health is a technology-driven healthcare startup focused on improving patient outcomes through ...